Boxer Capital Management’s F-star Therapeutics FSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,751,428
Closed -$12.8M – 93
2021
Q3
$12.8M Hold
1,751,428
– – 0.45% 56
2021
Q2
$15M Buy
+1,751,428
New +$14.9M 0.53% 56

Other funds holding FSTX

Boxer Capital Management's FSTX Position: Q4 2021 in Review

Boxer Capital Management sold out of F-star Therapeutics (FSTX) in Q4 2021, closing a stake of 1,751,428 shares — an estimated $12.8M sold.

Boxer Capital Management first reported a position in FSTX in Q2 2021 and held it in 2 quarters. The position peaked at $15M in Q2 2021. 43 funds tracked by Wall St. Rank hold FSTX as of Q4 2021.

  • Boxer Capital Management reported no remaining F-star Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Boxer Capital Management sold 1,751,428 F-star Therapeutics shares in Q4 2021, an estimated $12.8M.
  • Boxer Capital Management first reported a position in F-star Therapeutics in Q2 2021 and held it in 2 quarters.
  • Boxer Capital Management's F-star Therapeutics position peaked at $15M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held F-star Therapeutics as of Q4 2021.

Based on Boxer Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.